Your browser doesn't support javascript.
loading
Systematic evidence map (SEM) template: Report format and methods used for the US EPA Integrated Risk Information System (IRIS) program, Provisional Peer Reviewed Toxicity Value (PPRTV) program, and other "fit for purpose" literature-based human health analyses.
Thayer, Kristina A; Angrish, Michelle; Arzuaga, Xabier; Carlson, Laura M; Davis, Allen; Dishaw, Laura; Druwe, Ingrid; Gibbons, Catherine; Glenn, Barbara; Jones, Ryan; Phillip Kaiser, J; Keshava, Channa; Keshava, Nagalakshmi; Kraft, Andrew; Lizarraga, Lucina; Persad, Amanda; Radke, Elizabeth G; Rice, Glenn; Schulz, Brittany; Shaffer, Rachel M; Shannon, Teresa; Shapiro, Andrew; Thacker, Shane; Vulimiri, Suryanarayana V; Williams, Antony J; Woodall, George; Yost, Erin; Blain, Robyn; Duke, Katherine; Goldstone, Alexandra E; Hartman, Pam; Hobbie, Kevin; Ingle, Brandall; Lemeris, Courtney; Lin, Cynthia; Lindahl, Alex; McKinley, Kristen; Soleymani, Parnian; Vetter, Nicole.
Afiliação
  • Thayer KA; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: thayer.kris@epa.gov.
  • Angrish M; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: angrish.michelle@epa.gov.
  • Arzuaga X; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Arzuaga.Xabier@epa.gov.
  • Carlson LM; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Carlson.Laura@epa.gov.
  • Davis A; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Davis.Allen@epa.gov.
  • Dishaw L; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Dishaw.Laura@epa.gov.
  • Druwe I; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Druwe.Ingrid@epa.gov.
  • Gibbons C; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Gibbons.Catherine@epa.gov.
  • Glenn B; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Glenn.Barbara@epa.gov.
  • Jones R; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Jones.Ryan@epa.gov.
  • Phillip Kaiser J; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Kaiser.Jonathan-Phillip@epa.gov.
  • Keshava C; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Keshava.Channa@epa.gov.
  • Keshava N; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: keshava.nagu@epa.gov.
  • Kraft A; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: kraft.andrew@epa.gov.
  • Lizarraga L; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: lizarraga.lucina@epa.gov.
  • Persad A; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: persad.Amanda@epa.gov.
  • Radke EG; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: radke-farabaugh.elizabeth@epa.gov.
  • Rice G; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: rice.glenn@epa.gov.
  • Schulz B; Oak Ridge Associated Universities, TN, USA. Electronic address: schulz.brittany@epa.gov.
  • Shaffer RM; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Shaffer.rachel@epa.gov.
  • Shannon T; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Shannon.Teresa@epa.gov.
  • Shapiro A; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Shapiro.Andy@epa.gov.
  • Thacker S; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Thacker.Samuel@epa.gov.
  • Vulimiri SV; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Vulimiri.Sury@epa.gov.
  • Williams AJ; Center for Computational Toxicology and Exposure, US EPA, NC, USA. Electronic address: Williams.Antony@epa.gov.
  • Woodall G; Center for Public Health and Environmental Assessment, Health & Environmental Effects Assessment Division, US EPA, NC, USA. Electronic address: Woodall.George@epa.gov.
  • Yost E; Center for Public Health and Environmental Assessment, Chemical & Pollutant Assessment Division, US EPA, DC, USA. Electronic address: Yost.Erin@epa.gov.
  • Blain R; ICF, VA, USA. Electronic address: robyn.blain@icf.com.
  • Duke K; ICF, VA, USA. Electronic address: katie.duke@icf.com.
  • Goldstone AE; ICF, VA, USA. Electronic address: Ali.Goldstone@icf.com.
  • Hartman P; ICF, VA, USA. Electronic address: pamela.hartman@icf.com.
  • Hobbie K; ICF, VA, USA. Electronic address: kevin.hobbie@icf.com.
  • Ingle B; ICF, VA, USA. Electronic address: Ingle.Brandall@epa.gov.
  • Lemeris C; ICF, VA, USA. Electronic address: courtney.lemeris@icf.com.
  • Lin C; ICF, VA, USA. Electronic address: cynthia.lin@icf.com.
  • Lindahl A; ICF, VA, USA. Electronic address: alexander.lindahl@icf.com.
  • McKinley K; ICF, VA, USA. Electronic address: kristen.mckinley@icf.com.
  • Soleymani P; ICF, VA, USA. Electronic address: parnian.soleymani@icf.com.
  • Vetter N; ICF, VA, USA. Electronic address: nicole.vetter@icf.com.
Environ Int ; 169: 107468, 2022 11.
Article em En | MEDLINE | ID: mdl-36174483
ABSTRACT

BACKGROUND:

Systematic evidence maps (SEMs) are gaining visibility in environmental health for their utility to serve as problem formulation tools and assist in decision-making, especially for priority setting. SEMs are now routinely prepared as part of the assessment development process for the US Environmental Protection Agency (EPA) Integrated Risk Information System (IRIS) and Provisional Peer Reviewed Toxicity Value (PPRTV) assessments. SEMs can also be prepared to explore the available literature for an individual chemical or groups of chemicals of emerging interest.

OBJECTIVES:

This document describes the typical methods used to produce SEMs for the IRIS and PPRTV Programs, as well as "fit for purpose" applications using a variety of examples drawn from existing analyses. It is intended to serve as an example base template that can be adapted as needed for the specific SEM. The presented methods include workflows intended to facilitate rapid production. The Populations, Exposures, Comparators and Outcomes (PECO) criteria are typically kept broad to identify mammalian animal bioassay and epidemiological studies that could be informative for human hazard identification. In addition, a variety of supplemental content is tracked, e.g., studies presenting information on in vitro model systems, non-mammalian model systems, exposure-level-only studies in humans, pharmacokinetic models, and absorption, distribution, metabolism, and excretion (ADME). The availability of New Approach Methods (NAMs) evidence is also tracked (e.g., high throughput, transcriptomic, in silico, etc.). Genotoxicity studies may be considered as PECO relevant or supplemental material, depending on the topic and context of the review. Standard systematic review practices (e.g., two independent reviewers per record) and specialized software applications are used to search and screen the literature and may include the use of machine learning software. Mammalian bioassay and epidemiological studies that meet the PECO criteria after full-text review are briefly summarized using structured web-based extraction forms with respect to study design and health system(s) assessed. Extracted data is available in interactive visual formats and can be downloaded in open access formats. Methods for conducting study evaluation are also presented which is conducted on a case-by-case basis, depending on the usage of the SEM.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Saúde Ambiental Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Animals / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Saúde Ambiental Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Animals / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article